import type { Metadata } from "next";
import ClinicalArticleLayout from "@/components/ClinicalArticleLayout";

export const metadata: Metadata = {
  title: "Fasting Insulin, Hyperinsulinemia, and Early Metabolic Risk",
  description:
    "A clinical deep dive into fasting insulin, why normal glucose markers can miss early metabolic dysfunction, and how to act before cardiometabolic disease becomes obvious.",
  alternates: {
    canonical: "https://veridian.clinic/blog/fast-insulin",
  },
  openGraph: {
    title: "Fasting Insulin: The Missing Link in Early Metabolic Disease",
    description:
      "Why fasting glucose and HbA1c can look normal while hyperinsulinemia silently drives visceral fat, fatigue, and vascular risk.",
    url: "https://veridian.clinic/blog/fast-insulin",
    type: "article",
  },
};

const paragraph = {
  fontSize: ".96rem",
  color: "var(--sl2)",
  lineHeight: 1.95,
} as const;

const sectionHeading = {
  fontSize: "2rem",
  fontWeight: 500,
  color: "var(--sl)",
} as const;

export default function FastInsulinPage() {
  return (
    <ClinicalArticleLayout
      title="Fasting insulin, the missing early signal in metabolic disease"
      intro="Long before HbA1c rises or fasting glucose crosses a diagnostic threshold, insulin can already be elevated in the background. That compensatory phase is often where metabolic dysfunction begins, and it is exactly where early intervention has the greatest leverage."
      ctas={[
        { href: "/book?tier=metabolic-screen", label: "Book the Energy Screen — fasting insulin included →" },
        { href: "/metabolic-quiz", label: "Check your metabolic age free →", variant: "secondary" },
        { href: "/metabolic-reset-guide", label: "Get the 21-Day Reset Guide — £19.99", variant: "tertiary" },
      ]}
    >
      <p style={paragraph}>
        Fasting insulin is one of the most underused markers in preventive metabolic medicine. Many patients are told they are fine because their fasting glucose or HbA1c sits inside the laboratory reference range. But glucose is often the last thing to move. The body works hard to keep blood sugar stable, and it does that by producing more insulin. By the time glucose becomes obviously abnormal, the compensatory process may have been running for years.
      </p>
      <p style={paragraph}>
        That is why fasting insulin can be so clinically useful. It helps reveal how much hormonal effort is required to maintain apparently normal glucose. If insulin is already elevated, the system is under strain even if standard screening still looks reassuring.
      </p>
      <h2 className="cg" style={sectionHeading}>Why standard glucose markers can miss early dysfunction</h2>
      <p style={paragraph}>
        Early insulin resistance is often a story of compensation. Skeletal muscle becomes less responsive, the liver becomes more permissive of glucose output, and the pancreas answers by secreting more insulin. This can preserve normal glucose for a surprisingly long time. The patient may already have central weight gain, afternoon energy crashes, cravings, poor recovery, or fatty liver drift, yet their standard blood test still fails to make the case clearly.
      </p>
      <p style={paragraph}>
        In practical terms, fasting insulin can identify this earlier stage. It is not the only useful marker, but it often provides the missing clue that connects symptoms, body composition change, and long-term cardiometabolic risk.
      </p>
      <div style={{ padding: "18px 20px", background: "var(--iv)", borderLeft: "3px solid var(--go)" }}>
        <p style={{ fontSize: ".88rem", color: "var(--sl2)", lineHeight: 1.8 }}>
          <strong style={{ color: "var(--fo)" }}>Clinical bottom line:</strong> normal glucose does not always mean normal metabolism. Often it means insulin is still compensating.
        </p>
      </div>
      <h2 className="cg" style={sectionHeading}>Why elevated insulin matters</h2>
      <p style={paragraph}>
        Elevated insulin is not just a numerical curiosity. It changes the physiology. High insulin suppresses lipolysis, makes fat mobilisation more difficult, promotes a more storage-oriented metabolic state, and often tracks with visceral fat accumulation. It also clusters with elevated triglycerides, lower HDL, blood pressure drift, poorer energy stability, and eventually a more atherogenic lipid pattern.
      </p>
      <p style={paragraph}>
        This is why Veridian rarely interprets fasting insulin alone. We want to see it alongside HbA1c, fasting glucose, waist-to-height ratio, ApoB, triglycerides, liver markers, and where useful, CGM data. The point is pattern recognition, not single-number obsession.
      </p>
      <h2 className="cg" style={sectionHeading}>What actually improves fasting insulin</h2>
      <ul className="chk">
        <li>Resistance training to improve glucose disposal and insulin sensitivity.</li>
        <li>Improved meal structure, lower grazing frequency, and better protein intake.</li>
        <li>Waist reduction through sustainable body composition change.</li>
        <li>Sleep and recovery work, because poor sleep worsens insulin dynamics quickly.</li>
        <li>Objective measurement so progress is driven by data, not guesswork.</li>
      </ul>
      <p style={paragraph}>
        The strongest interventions are usually boring, but effective: better training, better sleep, better meal timing, and better body composition. When indicated, medication or more intensive support can also play a role. But the key is spotting the problem early enough that the system is still highly reversible.
      </p>
    </ClinicalArticleLayout>
  );
}
